Kostadinova R - Search Results

1

ARTD1 deletion causes increased hepatic lipid accumulation in mice fed a high-fat diet and impairs adipocyte function and differentiation.

Erener S, Mirsaidi A, Hesse M, Tiaden AN, Ellingsgaard H, Kostadinova R, Donath MY, Richards PJ, Hottiger MO. Erener S, et al. Among authors: kostadinova r. FASEB J. 2012 Jun;26(6):2631-8. doi: 10.1096/fj.11-200212. Epub 2012 Mar 16. FASEB J. 2012. PMID: 22426118

2

Poly(ADP-ribose)polymerase-1 (PARP1) controls adipogenic gene expression and adipocyte function.

Erener S, Hesse M, Kostadinova R, Hottiger MO. Erener S, et al. Among authors: kostadinova r. Mol Endocrinol. 2012 Jan;26(1):79-86. doi: 10.1210/me.2011-1163. Epub 2011 Nov 3. Mol Endocrinol. 2012. PMID: 22053002 Free PMC article.

3

Hypoxia causes down-regulation of 11 beta-hydroxysteroid dehydrogenase type 2 by induction of Egr-1.

Heiniger CD, Kostadinova RM, Rochat MK, Serra A, Ferrari P, Dick B, Frey BM, Frey FJ. Heiniger CD, et al. FASEB J. 2003 May;17(8):917-9. doi: 10.1096/fj.02-0582fje. Epub 2003 Mar 5. FASEB J. 2003. PMID: 12626438

4

Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1.

Kostadinova RM, Nawrocki AR, Frey FJ, Frey BM. Kostadinova RM, et al. FASEB J. 2005 Apr;19(6):650-2. doi: 10.1096/fj.04-2820fje. Epub 2005 Jan 19. FASEB J. 2005. PMID: 15659537

5

In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter: evidence for cell-specific regulation by Sp1 and Sp3.

Nawrocki AR, Goldring CE, Kostadinova RM, Frey FJ, Frey BM. Nawrocki AR, et al. Among authors: kostadinova rm. J Biol Chem. 2002 Apr 26;277(17):14647-56. doi: 10.1074/jbc.M111549200. Epub 2002 Feb 15. J Biol Chem. 2002. PMID: 11850421 Free article.

6

Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.

Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM. Ignatova ID, et al. Among authors: kostadinova rm. Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E367-77. doi: 10.1152/ajpendo.90531.2008. Epub 2008 Dec 16. Am J Physiol Endocrinol Metab. 2009. PMID: 19088256 Free article.

7

Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.

Apostolova G, Schweizer RA, Balazs Z, Kostadinova RM, Odermatt A. Apostolova G, et al. Am J Physiol Endocrinol Metab. 2005 May;288(5):E957-64. doi: 10.1152/ajpendo.00442.2004. Epub 2004 Dec 21. Am J Physiol Endocrinol Metab. 2005. PMID: 15613680 Free article.

8

PPARs in diseases: control mechanisms of inflammation.

Kostadinova R, Wahli W, Michalik L. Kostadinova R, et al. Curr Med Chem. 2005;12(25):2995-3009. doi: 10.2174/092986705774462905. Curr Med Chem. 2005. PMID: 16378501 Review.

9

GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation.

Kostadinova R, Montagner A, Gouranton E, Fleury S, Guillou H, Dombrowicz D, Desreumaux P, Wahli W. Kostadinova R, et al. Cell Biosci. 2012 Oct 10;2(1):34. doi: 10.1186/2045-3701-2-34. Cell Biosci. 2012. PMID: 23046570 Free PMC article.

10

A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.

Kostadinova R, Boess F, Applegate D, Suter L, Weiser T, Singer T, Naughton B, Roth A. Kostadinova R, et al. Toxicol Appl Pharmacol. 2013 Apr 1;268(1):1-16. doi: 10.1016/j.taap.2013.01.012. Epub 2013 Jan 23. Toxicol Appl Pharmacol. 2013. PMID: 23352505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters